| Net Cash Provided by (Used in) Operating Activities |
$2,676,000 |
USD |
-3009% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$4,225,000 |
USD |
-57% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$2,424,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$916,000 |
USD |
32% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$3,050,000 |
USD |
15% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$6,620,000 |
USD |
9.5% |
Q4 2024 |
FY 2024 |
| Depreciation |
$75,000 |
USD |
1.4% |
Q1 2025 |
Q1 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$54,000 |
USD |
238% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$37,000 |
USD |
-98% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$11,691,000 |
USD |
2.8% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$52,220,000 |
USD |
1.6% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$3,570,000 |
USD |
5.5% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$786,000 |
USD |
-2.6% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$1,987,000 |
USD |
217% |
Q1 2024 |
Q1 2024 |